Yuan, Xiaoyi http://orcid.org/0000-0002-2898-6495
Ruan, Wei http://orcid.org/0000-0002-2718-7923
Bobrow, Bentley
Carmeliet, Peter http://orcid.org/0000-0001-7961-1821
Eltzschig, Holger K. http://orcid.org/0000-0002-5676-6473
Article History
Accepted: 6 November 2023
First Online: 20 December 2023
Competing interests
: H.K.E., B.B. and X.Y. received research funding through a contract between Akebia Therapeutics and UTHealth to support a clinical trial on the effect of vadadustat in hospitalized patients with COVID-19 (NCT04478071). Akebia Therapeutics is not involved in conceptualization, design, data collection, analysis, decision to publish or preparation of the manuscript. W.R. and P.C. declare no competing interests.